Emerging drugs for the treatment of symptoms associated with autism spectrum disorders

Author： Wink Logan K Plawecki Martin H Erickson Craig A Stigler Kimberly A McDougle Christopher J

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.3, 2010-09, pp. : 481-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5186-5193

Bentham Science Publishers

Access to resources Recommend Favorite

Autism spectrum disorders: emerging pharmacotherapy

By Bostic Jeff Q King Bryan H

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 521-536

Informa Healthcare

Access to resources Recommend Favorite

Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 551-563

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin in Autism Spectrum Disorders

Current Clinical Pharmacology, Vol. 9, Iss. 4, 2014-11 ,pp. : 326-334

Bentham Science Publishers

Access to resources Recommend Favorite

New directions in the treatment of autism spectrum disorders from animal model research

By Chadman Kathryn K Guariglia Sara R Yoo Jiyeon Helen

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 407-416

Informa Healthcare

Access to resources Recommend Favorite